WHO Global Dialogue on Partnerships for …...WHO Global Dialogue on Partnerships for Sustainable...

WHO Global Dialogue on Partnerships for Sustainable Financing of

NCD Prevention and Control

Copenhagen Denmark 9-11 April 2018

of 24

PRELIMINARY PROVISIONAL AGENDA (ANNOTATED)

Dated 8 April 2018

Goal: – To share information on existing and potential sources of finance and development cooperation

at the local, national, regional and global levels and explore new opportunities for multi-

stakeholder and multisectoral partnerships in order to catalyze action for effective national NCD

responses.

Objectives: – Assess the progress made since 2011 in exploring the provision of funding for national NCD

responses through domestic, bilateral and multilateral channels, including traditional and voluntary innovative financing mechanisms

– Explore traditional funding patterns to mobilize resources for the prevention and control of NCDs through domestic, bilateral and multilateral channels, including international development cooperation

– Explore new financing streams to develop and implement national NCD responses for SDG 3.4,

including blended finance, public-private partnerships, pooled funding structures, and innovative financing mechanisms

– Showcase concrete examples of mechanisms to mobilize resources and increase financing for

national NCD responses – Address new and emerging issues, and the synergies between financing SDG 3.4 and broader

health systems strengthening efforts for Universal Health Coverage (UHC). – Reinvigorate and strengthen the financing for NCDs follow-up process




of 24

Monday, 9 April 2018

Monday, 9 April 2018 09:00-10:00| Opening ceremony: Welcome speeches by Government of Denmark and WHO (Tivoli Congress Center, Plenary Hall)

Aim: – Welcome speeches by Government of Denmark and WHO

Moderator/Master of Ceremony: – Martin Bille Hermann, State Secretary for Development Policy, Denmark Speakers: – H.R.H. Crown Princess Mary of Denmark – Ulla Tørnæs, Minister for Development Cooperation, Denmark – Svetlana Akselrod, Assistant Director General, WHO – Bente Mikkelsen, WHO – Dina Tadros, Youth Representative* Organised by: – Téa Collins, World Health Organization (WHO)

Rapporteur: – Line Neerup Handlos, WHO

* Acting as a facilitator of technical session




of 24

Monday, 9 April 2018 10:30-12:00| Plenary 1: Setting the Stage: The role of partnerships and innovative financing to accelerate national NCD responses (Tivoli Congress Center, Plenary Hall)

Aim: – Outline the objectives of the global dialogue to advance policy coherence in global NCDs

prevention and control efforts by and beyond 2030. Key questions: – Moving from MDGs to SDGs: What are the funding implications for national NCD prevention and

control?

– How to ensure NCD prevention and control are part of national UHC efforts? What are success

stories?

– What is the role of public-private partnerships in mobilizing resources for effective national NCD

responses?

Chair/Moderator:

– Martin Bille Hermann, State Secretary for Development Policy, Denmark

– Francesco Branca, WHO Keynote speaker: – Rifat Atun, Harvard University* Speakers: – Thomas Cueni, IFPMA – Adolfo Rubinstein, Minister of Health, Argentina – Agnes Soucat, WHO – Francine H.K. Ouedraogo Douamba, Ministry of Health, Burkina Faso – Waleed Almanea, Ministry of Health, Bahrain – Olivier Véran, National Parliament, France





of 24

Organised by: – Daniel Míc, WHO – Téa Collins, WHO Rapporteur: – Jakob Sloth Madsen; World Diabetes Foundation

Monday, 09 April 2018 13:00-15:00| Plenary 2: Development cooperation for NCDs: Aligning and leveraging domestic and external resources to achieve SDG3.4 (Tivoli Congress Center, Plenary Hall)

Key questions: – Where will the money come from to ensure the implementation of the 2030 Agenda for

Sustainable Development to achieve SDG3.4? – How much does burden of disease and cost-effectiveness actually determine the allocation of

resources? – How can development assistance be used to catalyse domestic funding in support of national

NCD responses? Chair/Moderator: – Téa Collins, WHO

Speakers: – Sanne Frost Helt, WHO GCM Working Group member* – Erika Placella, Swiss Agency for Development and Cooperation – Cary Adams, Union for International Cancer Control – George Shakarishvili, The Global Fund to Fight HIV/AIDS, TB and Malaria – Pablo Ferrari, Deputy Minister of Finance, Uruguay – Olayemi Cardoso, Citibank, Nigeria* – Tim Evans, World Bank (video message)

Organised by: – Téa Collins, WHO





of 24

Rapporteur: – Mads Loftager, World Diabetes Foundation

Monday, 9 April 2018 15:30-17:30| Parallel Session 2.1: Mobilizing resources for a joint UN system response to NCDs: The role of development cooperation (Tivoli Congress Center, Plenary Hall)

Aim: Going beyond financial assistance to include South-South, North-South and triangular technical cooperation, training, knowledge exchange programmes and knowledge-sharing networks

Key questions:

– Why is a whole-of-UN response required for the prevention and control of the NCD-related Sustainable Development Goals?

– What are Member States demanding from the UN system? How can the UN system accelerate and maximize its effectiveness in providing support to Member States? Where is its added value?

– What resources does the UN system currently have to support Member States and how is it currently responding?

– What are the challenges with regards a comprehensive UN system response to the NCD -related SDGs? What are the gaps?

– What is the role of development cooperation in scaling up domestic resource mobilization, strengthening health systems and improving NCD outcomes?

Chair/Moderator: – Nicholas Banatvala, UNIATF

Speakers:

– Thomas Bollyky, Council on Foreign Relations* – Douglas Webb, UNDP – Adolfo Rubinstein, Minister of Health, Argentina – Carlotta Barcaro, UNICEF – May Abdel-Wahab, IAEA





of 24

– Stineke Oenema, UNSCN – Anselm Hennis, PAHO/WHO AMRO – Ani Shakarishvili, UNAIDS Organised by: – Alexey Kilukov, WHO – Nick Banatvala, WHO

Rapporteur: – Kirza Kristensen, World Diabetes Foundation

Monday, 9 April 2018 15:30-17:30| Parallel Session 2.2: Mobilizing domestic resources for NCDs: Learning from country experiences (Tivoli Congress Center, Harlekin)

Key Questions:

– What are the opportunities and challenges for domestic resource mobilization for health in low- and middle-income countries? What is needed to ensure the priority for health and NCD response in the budgetary processes?

– What are the experiences of and lessons learned by countries in implementing taxes on the use of tobacco, alcohol, sugar-sweetened beverages and other health-harming products in financing national NCD responses?

– What are the country experiences/lessons learned from earmarking taxes for health?

Co-moderators: – Kristina Mauer-Stender, WHO – Fernando Araujo, Secretary of State for Health, Portugal

Speakers: – Carlos Eduardo de Oliveira Lula, Ministry of Health, Brazil – Agnes Soucat, WHO – Oxana Domenti, Parliament of Republic of Moldova

– Tanel Ross, Ministry of Finance, Estonia

– Jeremias Paul, WHO




of 24

Organised by: – Marge Reinap, WHO

Rapporteur: – Amelie Keller, WHO

Monday, 9 April 2018 15:30-17:30|Parallel Session 2.3: How to harness the power of the private sector to implement national NCD responses

(Tivoli Congress Center, Pjerrot)

Key questions:

– What are the new business models and financing mechanisms needed to accelerate the delivery of the NCD targets?

– What are the incentives for private sector engagement in development processes at country level to complement Governments’ efforts for NCD prevention and control?

– What are examples of successful public-private partnerships for NCD responses? What are the challenges and mechanisms to address them?

Chair/Moderator:

– Vanessa Candeias, World Economic Forum – Bent Lautrup-Nielsen, World Diabetes Foundation

Speakers:

– David Clarke, WHO – Stephane Besançon, Santé Diabète – Andrea Atzori, Doctors with Africa Cuamm – Kaushik Ramaiya, Tanzania Diabetes Association – Niels Lund, IFPMA

Organised by: – Vanessa Candeias, World Economic Forum – Bent Lautrup-Nielsen, World Diabetes Foundation

Rapporteurs:

– Elsa Morandat, World Diabetes Foundation – Susanne Olejas, World Diabetes Foundation




of 24

Monday, 9 April 2018 15:30-17:30|Parallel Session 2.4: Measuring resource flows into NCDs: Current trends and projections (Tivoli Congress Center, Columbine)

Key questions: – What are the major global funding sources for NCD prevention and control? – What are the challenges of measuring resource flows into NCD prevention and control?

What does catalytic financing mean, and what are concrete examples? What are the roles and responsibilities of bilateral agencies, national governments, multilaterals, and the various relevant private sector companies in this regard?

Chair/Moderator: – Dorje Mundle, Expert*

Speakers: – Brenda Killen, OECD – Rachel Nugent, RTI International* – Hafeez Ladha, Financing Alliance for Health – Harald Nusser, IFPMA

Organised by: – Andrea Feigl, OECD Rapporteur: – Andrea Feigl, OECD

Monday, 9 April 2018 18:30-20:30 | Official welcome reception (Tivoli Congress Center, Foyer)





of 24

Tuesday, 10 April 2018

Tuesday, 10 April 2018 9:00-11:00 | Plenary 3: Exploring synergies between financing national NCD responses and broader health systems strengthening efforts for universal health coverage (UHC) – Launch of the report of the Lancet Taskforce on NCDs and Economics (Tivoli Congress Center, Plenary Hall)

Key questions:

– Are the current healthcare financing systems fit for purpose for the new expanded development

agenda? What are the challenges? Solutions?

– How to protect the poor and near-poor from NCD-related medical impoverishment? Examples of

what works … and doesn’t.

– How to make a good investment case to prioritize NCDs in public budgets?

– What next steps are needed to generate additional NCD financing and ensure it is being spent

well?

Chair/Moderator:

– Jennifer Sargent, The Lancet*

Speakers: – Rachel Nugent, RTI International* – Franco Sassi, Imperial College Business School, London, UK* – Louis Niessen, Liverpool School of Tropical Medicine, UK* – Stephen Jan, University of New South Wales, Sydney, Australia* – Hans Kluge, WHO – Mark Pearson, OECD – Melanie Bertram, WHO





of 24

Organised by:

– Rachel Nugent, RTI International* Rapporteur:

– Mads Loftager, World Diabetes Foundation

Tuesday, 10 April 2018 11:30-13:30 | Parallel session 3.1: Political economy of UHC for NCDs: What are the necessary economic, social and political preconditions to make UHC for NCDs a realistic goal for all? (Tivoli Congress Center, Harlekin)

Key questions: – Is there a link between the progress on UHC and political commitment, policy pathways, funding

and governance arrangements?

– How have countries achieved UHC? What are the success factors?

– Would healthcare systems be socially and economically sustainable without UHC that

incorporates comprehensive NCD prevention and control?

– What is the role of evidence and implementation research in achieving UHC goals?

Chair/Moderator: – Celine Gorre, Global Alliance for Chronic Diseases Speakers: – Adolfo Rubenstein, Minister of Health, Argentina – Joao Rodrigues Da Silva Breda, WHO – Vilma Irazola, Centre of Excellence in Cardiovascular Health in South America, Institute of

Effective Clinical Healthcare, Argentina – Madiha Ahmed, International Development and Research Centre, Canada

Organised by: – Celina Gorre, Global Alliance for Chronic Diseases Rapporteur: – Elizaveta Lebedeva, WHO




of 24

Tuesday, 10 April 2018 11:30-13:30 | Parallel session 3.2: Investing in innovative service delivery models towards Integrated person-centered care for NCDs (Tivoli Congress Center, Pjerrot)

Key questions: – What are the innovative service delivery models to allow better management and integration of

NCDs at PHC level?

– What are the implications of integrating NCDs into other programmatic areas in terms of cost,

efficiency, equity and quality of care?

– What are the challenges? Success stories?

Chair/Moderator: – Bent Lautrup-Nielsen, World Diabetes Foundation Speakers: – Sanne Frost Helt, WHO GCM Working Group member* – Jonathan Klein, American Academy of Pediatrics – Nicole Denjoy, DITTA – Simon Barquera, National Institute of Public Health Mexico – Gene Bukhman, Harvard Medical School

Organised by: – Bent Lautrup-Nielsen, World Diabetes Foundation Rapporteur:

– Elsa Morandat, World Diabetes Foundation – Susanne Olejas, World Diabetes Foundation





of 24

Tuesday, 10 April 2018 11:30-13:30 | Parallel session 3.3: Building the investment case for NCD prevention and control (Tivoli Congress Center, Plenary Hall)

Key questions: – Are NCD investment cases a useful tool to demonstrate high health, social and economic returns

on investments in NCD prevention and control?

– Can NCD investment cases ensure that NCD interventions are considered as high value within

publicly supported benefit packages?

– What are the challenges and key enablers to ensure the implementation and scale-up of

effective NCD interventions?

– What can we learn from country experience with investment cases and their resulting impact?

Chair/Moderator: – Nick Banatvala, WHO Speakers: – Douglas Webb, UNDP – Rachel Nugent, RTI International * – Andrea Feigl, OECD – Katie Dain, NCD Alliance – Omar Shengiti, Ministry of Health, Saudi Arabia – Stineke Oenema, UNSCN – Purwanto, Ministry of Finance, Indonesia – Robert Tripp, FCTC Organised by: – Nick Banatvala, WHO Rapporteur: – Jakob Sloth Madsen, World Diabetes Foundation





of 24

Tuesday, 10 April 2018 11:30-13:30 | Parallel session 3.4: Cost-effective and feasible solutions: WHO ‘best buys’ (Tivoli Congress Center, Columbine)

Aim: – Showcase country-level experiences, lessons learned and good practices in financing and

implementing ‘Best Buys’ policies for NCD prevention and control – Identify key strategies and approaches for financing implementation and scale-up of the ‘Best

Buys’ policies – Approaches to intensify action for the implementation and scale-up of the ‘Best Buys’ policies

Key questions: – What are the ‘Best Buys’? – Countries experiences in financing and implementation; – Capital investment in health to better address NCDs: securing value for money and performance; – Approaches for intensified action. Chair/Moderator: – Mary-Anne Land, WHO Speakers/Panelists:

– Melanie Bertram, WHO

– Dian Black, Ministry of Finance and Public Service, Jamaica

– Frederico Bosco Alves dos Santos, Ministry of Health, Timor-Leste

– Justice Mudavanhu, Ministry of Health, Zimbabwe

– Gwenael Dhaene, WHO

– Ajitha Botagoda, Ministry of Finance and Mass Media, Sri Lanka

– Thaksaphon Thamarangsi, WHO

Organised by: – Mary-Anne Land, WHO




of 24

Rapporteur: – Hanne Strandgaard, World Diabetes Foundation


14:30-16:30 | Partnership Forum 1: Scaling up digital health for NCDs: Leaving no one behind

(Tivoli Congress Center, Plenary Hall)

Key questions: – How do we scale up mobile health to address the SDGs leaving no one behind? – Can digital technology such as BHBM optimize the costs, the impact and the scalability of health

related interventions? – Is digital technology a mean to reduce health inequality? Chair/Moderator: – Mary-Anne Land, WHO

Speakers: – Fiona Adshead, NCD Alliance – Clayton Hamilton, WHO – Thomas Cueni, IFPMA – Birgit Mirlion, European Commission – Pasqualino Procacci, Agency for Development Cooperation, Italy

Organised by: – Marta Guglielmetti, WHO – Mary-Anne Land, WHO Rapporteur: – Kirza Kristensen, World Diabetes Foundation




of 24


14:30-16:30 | Partnership Forum 2: NCDs and mental health in emergencies: Beyond current

financing

(Tivoli Congress Center, Arkaden 6 (second floor))

Key questions: – What needs to be done to ensure the inclusion of NCD and mental health as part of humanitarian

assistance? In terms of framing/advocacy, funding proposal and operational planning?

– What changes to current financing mechanisms are required to enhance the inclusion of NCD

and mental health as part of humanitarian assistance?

– What positive steps are being taken by donors to ensure better inclusion of NCD and mental

health as part of emergency responses?

– What can we learn from current emergency responses? What are the challenges? Success

stories?

– How can donors and the global humanitarian community support the transition from emergency

to recovery and support strengthening of national NCD and mental health programmes?

Chair/Moderator: – Daniel Hugh Chisholm, WHO Speakers: – Sarah Harrison, International Federation of Red Cross Red Crescent Societies – Representative of European Civil Protection and Humanitarian Aid Operations (TBC) – Birgitte Bischoff Ebbesen, Danish Red Cross – Slim Slama, WHO Organised by: – Slim Slama, WHO Rapporteur: – Line Neerup Handlos, WHO




of 24

Tuesday, 10 April 2018 14:30-16:30 | Partnership Forum 3: A vital investment: Scaling up health workforce for NCDs (Tivoli Congress Center, Columbine)

Key questions: – What are the investment needs to strengthen countries’ capacities to develop HRH policies and

plans in line with national health strategies to achieve UHC and SDG3.4? – What are the challenges for adequate and efficient sustainable financing for developing the ‘fit

for purpose’ health workforce in resource-constrained environments? – What is the role of various sectors (civil society, professional associations, private sector), as well

as development partners in advancing the HRH agenda to support scale-up of the health workforce to address the growing burden of NCDs?

Chair/Moderator: – Francesca Celletti, Corvus Health Speakers/Panelists: – Isabel Jacinto, National Association of Pharmacies, Portugal – Sanne de Wit, International Federation of Medical Students’ Associations – Andreas Rudkjøbing, World Medical Association – Feven Girma Assefa, Ministry of Health, Ethiopia

– Patrick Kupelian, Varian Medical Systems* Organised by: – Baptiste Vasey, Mercator Fellowship* – Julia Tainijoki Seyer, World Medical Association Rapporteur: – Baptiste Vasey, Mercator Fellowship*





of 24

Tuesday, 10 April 2018 14:30-16:30 | Partnership Forum 4: Accelerating access to medicines and new technologies in low- and middle-income countries: Viable models for innovative partnerships (Tivoli Congress Center, Pjerrot)

Key questions: – What are the financial and non-financial barriers to the availability of appropriate NCD, quality-

assured medicines and products (NMPs) in public facilities? (e.g. underfunding or under-budgeting, inaccurate demand forecasting, inefficient public sector procurement or distribution of medicines, lack of effective regulation for quality and safe use of medicines)

– How can the private sector be engaged to accelerate access to NCD medicines and new technologies in low-and middle income countries?

– What are the examples of successful public-private partnerships? Challenges? Success factors?

Chair/Moderator: – Helen McGuire, PATH Speakers: – James Pfitzer, IFPMA* – Soraya Ramoul, IFPMA – Gerald Mutungi, Ministry of Health, Uganda – Dorcas Kiptui, Ministry of Health, Kenya Organised by: – James Pfitzer, IFPMA* – Vanessa Peberdy, IFPMA Rapporteur: – Grega Kumer, IFPMA





of 24

Tuesday, 10 April 2018 14:30-16:30 | Partnership Forum 5: Advocacy for resource mobilization for NCDs: The role of civil society for holding stakeholders accountable

(Tivoli Congress Center, Harlekin)

Key questions: – What is the role of civil society in resource mobilization for NCDs at national and global levels? – How can grass-roots advocacy be scaled up to convince Governments to invest in the prevention

and treatment of NCDs? – What are the challenges of holding Governments and other stakeholders accountable for taking

action? Success stories, country examples?

Chair/Moderator: – Katie Dain, NCD Alliance Speakers: – Stéphane Besancon, Santé Diabéte – Stefan Islandi, Danish Cancer Society – Tih Ntiabang, Framework Convention Alliance, Cameroon – Ishu Kataria, Young Professionals Chronic Disease Network Organised by: – Priya Kanayson, NCD Alliance Rapporteur: – Priya Kanayson, NCD Alliance

Tuesday, 10 April 2018 14:30-16:30 | Partnership Forum 6: Creating a shared value: Aligning commercial and public health interests to tackle NCDs

(Tivoli Congress Center, Arkaden 7 (second floor))




of 24

Key questions: – What are the most effective collaboration models for governments, health professionals,

insurance companies and other private sector entities to work together to prevent and control NCDs?

– How can we increase the level of evidence on health-related externalities to better align commercial and public health interests to tackle NCDs?

– Which innovative financing mechanisms could provide incentives to address the burden of NCDs? Chair/Moderator: – Ilona Kickbusch, Global Health Centre, Graduate Institute Geneva*

Speakers: – David Clarke, WHO – Dorje Mundle, Expert* – Ann-Marie Sevcsik, UBS Optimus Foundation

– Franck Droin, European Association of Paritarian Institutions – Rachel Melsom, Tobacco Free Portfolios

– Martin Bernhardt, IFPMA

Organised by: – Sophie Genay-Dillautas, WHO – Baptiste Vasey, Mercator Fellowship* Rapporteur: – Rachel Melsom, Tobacco Free Portfolios – Eiizaveta Lebedeva, WHO

Tuesday, 10 April 2018 17:00-18:00 | Plenary 4: Debriefing from partnership fora – Current and new financing models, partnerships, mechanisms, policies and frameworks



http://en.wikipedia.org/wiki/Paritarian_Institutions

http://en.wikipedia.org/wiki/Paritarian_Institutions




of 24

Aim: – Summarize the outcomes/key messages emerging from each partnership session

– Exchange good practices on resource mobilization to address NCDs through partnerships

– Identify opportunities where partnerships can add value by aligning public and private interests

Chair/moderator: – Franco Sassi, Imperial College Business School * Speakers: – Slim Slama, WHO – Baptiste Vasey, Mercator Fellowship* – James Pfitzer, IFPMA* – Katie Dain, NCD Alliance – Rachel Melsom, Tobacco Free Portfolios – Bent Lautrup-Nielsen, World Diabetes Foundation

Organised by:

– Baptiste Vasey, Mercator Fellowship* Rapporteur: – Dina Tadros, Youth Representative*

Wednesday, 11 April 2018

Wednesday, 11 April 2018 9:00-10:30 | Plenary 5: Synthesis: Summary, conclusion & recommendations






of 24

Key questions: – What are the key strategies and mechanisms identified from the WHO Global Dialogue Sessions

to mobilize resources for NCD prevention and control? – How can public and private interests be aligned to accelerate action towards achieving SDG 3.4? – What are the examples of best initiatives/partnerships for leveraging and catalysing public and

private financing of national NCD responses? – What are the major sources of innovative financing mechanisms available to enhance South-

South and triangular development cooperation on NCD prevention and control? – What are the gaps that need to be highlighted and addressed for future efforts? Chair/Moderator: – Ilona Kickbusch, Global Health Centre, Graduate Institute Geneva * Speakers: – Cristina Gonzalez, Permanent Mission of Uruguay to the United Nations Organizations in Geneva – Katie Dain, NCD Alliance – Celina Gorre, Global Alliance for Chronic Diseases* – David Clarke, WHO – Jennifer Healy, Department of Health and Human Services, USA – Kaushik Ramaiya, Tanzania Diabetes Association – Rifat Atun, Harvard University – Nick Banatvala, WHO Organised by: – Dina Tadros, Youth Representative* Rapporteur:

– Bent Lautrup-Nielsen, World Diabetes Foundation

Wednesday, 11 April 2018 11:00-12:30 | Plenary 6: Multistakeholder and multisectoral action: A means to unlock financing for NCDs (Tivoli Congress Center, Plenary Hall)





of 24

Key questions: – Public resources are not sufficient to overcome the NCD challenge. Incentives are needed for the

private sector to support financing of national NCD responses. What is the role of public-private partnerships in mobilizing resources for effective national NCD responses? What are the success stories?

– While traditional funding patterns and public-private partnerships are critical for mobilizing resources internationally and domestically to curb the NCD epidemic, what innovative and alternative sources and partnership modalities for collaboration have also proven successful?

– How can public and private sectors come together to create a shared value for the achievement of common public health goals?

Chair/Moderator: – Guy Fones, WHO Keynote speakers: – Grete Faremo, UNOPS – Kristian Jensen, Minister of Finance, Denmark Speakers: – HRH Princess Dina Mired, Union for International Cancer Control – Bente Mikkelsen, WHO – Bagher Larijani, Ministry of Health and Medical Education, Iran – Raquel Rosa, Ministry of Health, Uruguay – Mohammed Hamad Al Thani, Ministry of Public Health, Qatar – Sania Nishtar, Co-chair WHO Independent High-level Commission on NCDs (video statement) Organised by: – Guy Fones, WHO

Rapporteur: - Jakob Sloth Madsen, World Diabetes Foundation

Wednesday, 11 April 2018 12:30-12:45 | Call to Action (Tivoli Congress Center, Plenary Hall)




of 24

Speakers: – Martin Bille Hermann, State Secretary for Development Policy, Denmark

Wednesday, 11 April 2018 12:45-13:00 | Closing of the meeting (Tivoli Congress Center, Plenary Hall)

Speakers: Co-organisers: – Representative of WHO – Representative of the Government of Denmark




of 24

Disclaimer This provisional agenda (annotated) does not reflect the actual order of speakers. The designations employed and the presentation of the material in this annotated agenda (annotated) do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers or boundaries. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this provisional agenda (annotated). The World Health Organization does not warrant that the names, functions and institutions contained in this annotated agenda are complete and correct and shall not be liable for any damages incurred as a result of its use. This provisional agenda (annotated) is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the presentation lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. Attendance to this global dialogue is by invitation only.

WHO Global Dialogue on Partnerships for …...WHO Global Dialogue on Partnerships for Sustainable...

Documents

Transcript of WHO Global Dialogue on Partnerships for …...WHO Global Dialogue on Partnerships for Sustainable...